Avience Biomedicals Ltd vs Molbio Diagnosti
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Avience Biomedicals Ltd currently has the stronger revenue growth signal.
Avience Biomedicals Ltd and Molbio Diagnosti show active capex signals based on earnings call analysis.
Avience Biomedicals Ltd show fundraising activity or capital structure signals.
| Metric | Avience Biomedicals Ltd | Molbio Diagnosti |
|---|---|---|
| Current Price | ₹267 | ₹1,574.4 |
| Market Cap | ₹146.4 Cr. | ₹18,143.38 Cr. |
| Industry | Healthcare Equipment & Supplies | Healthcare Equipment & Supplies |
| P/E Ratio | 16.75 | 83.57 |
| ROE (%) | 32.33 | 13.84 |
| Debt/Equity | 0.92 | 0.3 |
| Sales Growth 5Y (%) | — | 0.65 |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | 64.59 | 41.29 |
| Revenue Rank | Rank 1 | Rank 2 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | Yes | No information |